Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mutations Selectively Evolving Peroxidase Activity Among Alternative Catalytic Functions of Human Glutathione Transferase P1-1.

Antioxidants (Basel, Switzerland)·2024
Same author

Supreme glutathione-dependent ketosteroid isomerase in the yellow-fever transmitting mosquito Aedes aegypti.

Biochemical and biophysical research communications·2024
Same author

Human GST P1-1 Redesigned for Enhanced Catalytic Activity with the Anticancer Prodrug Telcyta and Improved Thermostability.

Cancers·2024
Same author

Versatility of Glutathione Transferase Proteins.

Biomolecules·2023
Same author

Conservation of Glutathione Transferase mRNA and Protein Sequences Similar to Human and Horse Alpha Class GST A3-3 across Dog, Goat, and Opossum Species.

Biomolecules·2023
Same author

Potent GST Ketosteroid Isomerase Activity Relevant to Ecdysteroidogenesis in the Malaria Vector <i>Anopheles gambiae</i>.

Biomolecules·2023

相关实验视频

Updated: Jul 7, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

谷氨转移酶催化抗瘤2-crotonyloxymethyl-2-cycloalkenones转化为GSH添加物的机制

Diana S Hamilton1, Xiyun Zhang, Zhebo Ding

  • 1Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, Maryland 21250, USA. hamilton@umbc.edu

Journal of the American Chemical Society
|December 5, 2003
PubMed
概括

人类的谷氨转移酶会代谢抗瘤药物,如COMC-6,COMC-7和COMC-5. 这项研究阐明了反应机制,并确定了参与处理这些化合物的关键酶异型.

更多相关视频

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

相关实验视频

Last Updated: Jul 7, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

科学领域:

  • 生物化学 生物化学
  • 酶学 是一种酶学.
  • 药物新陈代谢 药物新陈代谢

背景情况:

  • 谷氨转移酶 (GSTs) 是关键的酶,参与了异生菌的排毒.
  • 某些GST异酶在潜在的化疗剂的代谢中发挥作用.

研究的目的:

  • 研究人类谷氨转移酶P1-1 (hGSTP1-1) 在处理COMC-6,COMC-7和COMC-5中的动力效率.
  • 阐明这些COMC衍生物的谷氨联机制.
  • 为了确定能够催化这些反应的特定GST异酶.

主要方法:

  • 用各种COMC衍生物作为基质进行酶动力学测试.
  • 使用质谱法和奇拉标签对反应产物的分析.
  • 分子对接研究,以调查酶活性部位相互作用.

主要成果:

  • hGSTP1-1高效地加工了COMC-6,COMC-7和COMC-5,产生了独特的谷氨酸化产品.
  • 一个拟议的机制涉及迈克尔添加,非立体特异化,以及随后的GSH位移.
  • 多个人类GST同酶 (hGSTP1-1,hGSTA1-1,hGSTA4-4,hGSTM2-2) 显示了对COMC-6的类似催化效率.

结论:

  • 该研究详细介绍了GSTs参与COMC衍生物代谢的酶和化学步骤.
  • 这些发现突显了GST在这些抗瘤剂的代谢中的潜在作用,与多药性耐药性有关.
  • 在hGSTP1-1中Tyr108可能在反应机制中充当一般酸催化剂.